Commentary · 28 Mar 2024
ArticlePublished 30 Jun 2023
Fragment-based Drug Design (FBDD)
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Fragment-based drug design (FBDD) is a powerful approach used in drug discovery and development to identify and optimize small, fragment-sized molecules into potent and selective drug candidates. It has gained significant attention and popularity in the pharmaceutical industry due to its ability to overcome some of the challenges associated with traditional high-throughput screening (HTS) methods. In traditional HTS, large libraries of diverse compounds are screened against a biological target to identify hits that bind and modulate the target’s activity. While HTS has been successful in identifying lead compounds, it often faces limitations such as compound promiscuity, poor selectivity, and the need for extensive synthetic modifications to optimize the hits into drug candidates. Fragment-based drug design, on the other hand, offers a more rational and efficient approach to lead discovery and optimization. Fragment-based drug design (FBDD) is a powerful strategy used in the development of new pharmaceutical compounds. This approach involves the identification and optimization of small, low molecular weight fragments that bind to a specific target protein or receptor, followed by their assembly into larger compounds with improved potency and selectivity. FBDD offers several advantages over traditional drug discovery methods, including the ability to explore a larger chemical space, the potential for rapid lead discovery, and the ability to target protein-protein interactions. In this review, we discuss the principles and techniques of FBDD, highlight its successful applications in drug discovery, and provide an overview of the challenges and future prospects of this approach.
Subjects
ChemistryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Opinion · 30 Oct 2025
Fragment-based Drug Discovery: Emerging Strategies and Applications
Article · 28 Apr 2025
Fragment-Based Lead Discovery: A Strategic Approach to Drug Development
Conference abstract · 7 Jun 2017
Adapting DNA-encoded library technology for fragment-based drug discovery
Perspective · 26 Jun 2024
Enhancing Drug Efficacy through Fragment-Based Design: A Perspective in Advancing Drug Discovery
More from this journal
The newest in Journal of Medicinal and Organic Chemistry.
Article · 31 Dec 2025
Organosilicon Compounds in Medicinal Chemistry: Expanding the Chemical Toolbox
Article · 31 Dec 2025
Reactive Intermediate Studies: Unlocking Mechanistic Insights in Chemistry
Article · 31 Dec 2025
Lipid-Based Drug Delivery: Enhancing Therapeutic Efficiency and Targeting
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Medicinal and Organic Chemistry
- SubjectChemistry
- BylineArticles whose byline prints “Dr. Alika Farhan”
